NCT02067351

Brief Summary

There is evidence that mindfulness-based interventions (MBIs) such as meditation, mindfulness-based stress reduction (MBSR) and yoga might improve Quality of Life (QOL) and reduce stress in breast cancer survivors. These interventions are becoming increasingly popular in cancer survivors. However, little is known about the feasibility and effect of MBIs administered during the interval of time of chemotherapy, on QOL and stress. The investigators are planning a MBI intervention study developed specifically for breast cancer survivors receiving chemotherapy (usually 4-5 months) at the investigators institution, for at least 8 sessions combined with at least 8 weeks of home-practice, in 25 women receiving chemotherapy for breast cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for phase_2 breast-cancer

Timeline
Completed

Started Apr 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 20, 2014

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2014

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

March 3, 2020

Status Verified

February 1, 2020

Enrollment Period

2.8 years

First QC Date

February 15, 2014

Last Update Submit

February 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility - percentage of patients recruited from those approached, percentage of patients who dropped off, percentage of patients who are compliant (attending more than 75% of recommended sessions)

    While receiving chemotherapy (usually 4-5 months)

Secondary Outcomes (1)

  • Stress - measured by the Perceived Stress Scale - statistically and clinically significant reductions in stress

    7-8 months

Other Outcomes (3)

  • Fatigue - Multidimensional Fatigue Symptom Inventory -Short Form statistically and clinically significant reductions in fatigue score

    7-8 months

  • Quality of life measured by the Functional Assessment of Cancer Therapy - Breast - statistically and clinically significant improvement in quality of life

    7-8 months

  • Sleep measured by the Pittsburgh Sleep Quality Index -statistically and clinically significant improvements in sleep

    7-8 months

Study Arms (1)

Mindfulness Intervention

EXPERIMENTAL

Mindfulness intervention

Behavioral: Mindfulness

Interventions

MindfulnessBEHAVIORAL

Meditation, body scan, yoga.

Mindfulness Intervention

Eligibility Criteria

Age20 Years - 75 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women 20-75 years old
  • Diagnosed with breast cancer
  • Scheduled to begin chemotherapy at Mayo Clinic Rochester

You may not qualify if:

  • Pregnant
  • Practicing mindfulness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Daniela Stan, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Daniela Stan, MD

Study Record Dates

First Submitted

February 15, 2014

First Posted

February 20, 2014

Study Start

April 1, 2014

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

March 3, 2020

Record last verified: 2020-02

Locations